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Abstract 
Background 
Mindful-based interventions improve functioning and quality of life in fibromyalgia (FM) 
patients. The aim of the study is to perform a psychometric analysis of the Spanish version of 
the Mindful Attention Awareness Scale (MAAS) in a sample of patients diagnosed with FM. 
Methods 
The following measures were administered to 251 Spanish patients with FM: the Spanish 
version of MAAS, the Chronic Pain Acceptance Questionnaire, the Pain Catastrophising 
Scale, the Injustice Experience Questionnaire, the Psychological Inflexibility in Pain Scale, 
the Fibromyalgia Impact Questionnaire and the Euroqol. Factorial structure was analysed 
using Confirmatory Factor Analyses (CFA). Cronbach's α coefficient was calculated to 
examine internal consistency, and the intraclass correlation coefficient (ICC) was calculated 
to assess the test-retest reliability of the measures. Pearson’s correlation tests were run to 
evaluate univariate relationships between scores on the MAAS and criterion variables. 
Results 
The MAAS scores in our sample were low (M = 56.7; SD = 17.5). CFA confirmed a two-
factor structure, with the following fit indices [sbX2 = 172.34 (p < 0.001), CFI = 0.95, GFI = 
0.90, SRMR = 0.05, RMSEA = 0.06. MAAS was found to have high internal consistency 
(Cronbach’s α = 0.90) and adequate test-retest reliability at a 1–2 week interval (ICC = 0.90). 
It showed significant and expected correlations with the criterion measures with the exception 
of the Euroqol (Pearson = 0.15). 
Conclusion 
Psychometric properties of the Spanish version of the MAAS in patients with FM are 
adequate. The dimensionality of the MAAS found in this sample and directions for future 
research are discussed. 
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Background 
In the last 20 years, an increasing number of studies have been dedicated to research on 
mindfulness and the use of mindfulness training as a clinical intervention for diverse physical 
and mental disorders. Mindfulness refers to an awareness that emerges by paying attention to 
purpose and to the present moment and non-judgmentally focusing on the unfolding of one’s 
immediate experience [1,2]. Mindfulness is a skill that can be taught using several uniquely 
designed techniques [3]. 
Mindfulness-based therapies have been demonstrated to be effective for the treatment of 
many disorders, including chronic pain conditions [4-6]. The mechanisms underlying the 
effects that mindfulness training has on health are diverse and include increased attention 
control, increased awareness of inner experiences, increased emotional regulation, and 
changes in the concept of self or in body awareness [7]. 
Mindfulness training in the treatment of fibromyalgia (FM) has been shown to decrease pain 
symptoms and to improve overall quality of life; as such, mindfulness training is considered a 
promising supplement to current interventions [4,8-10]. Despite these findings, there is still a 
lack of understanding of the mechanisms that underlie the mitigating effects of mindfulness 
on pain symptoms. Research studies on such mitigating effects suggest that mindfulness 
alters the contextual evaluation of pain [5], reduces pain catastrophising and pain sensitivity 
[6], reduces psychopathological symptoms [11,12], and alters pain-related anxiety [13]. 
These results have not been contradicted in the three years since their discovery [9]. 
Recent findings suggest that pain acceptance, which is promoted by mindfulness 
interventions, improves functioning and life quality. However, there is still a lack of reliable 
and valid instruments to assess relevant processes in such interventions [14]. It is assumed 
that if mindfulness is a learned skill, then a measure of mindfulness should demonstrate both 
incremental validity [15] and sensitivity to change. Furthermore, the expected changes (for 
example, improvement in quality of life or decrease in symptoms) should be directly related 
to changes in mindfulness. 
There are several questionnaires that measure mindfulness, with the two the most commonly 
used being the Five-Facets Mindfulness Questionnaire (FFMQ) [16] and the Mindful 
Attention Awareness Scale (MAAS) [17]. The FFMQ is considered one of the most complete 
questionnaire because it measures five component skills of mindfulness: observing, 
describing, acting with awareness, nonjudging of inner experience and nonreactivity to inner 
experience. However, the MAAS is the most popular scale measuring mindfulness, with over 
350 citations in the Web of Science [18]. The MAAS has shown theoretically consistent 
relationships to brain activity [19], treatment outcome in mindfulness-based interventions 
(MBIs) [20] and mediation of targeted MBI outcomes [21].” 
The authors that developed the MAAS define mindfulness as “the presence or absence of 
attention to, and awareness of, what is occurring in the present moment”. The MAAS is a 15-
item scale developed to measure the frequency of mindful states in daily life. Translated 
variants of this scale have been validated in several languages, including Spanish [22], 
Chinese [23], Swedish [24], Turkish [25] and French [26]. 
The original Spanish scale was validated and developed in a sample of Spanish non-clinical 
participants. [22]. Within the clinical population, the MAAS has been validated only in a 
sample of cancer patients [27]. The validation of scales in specific clinical samples is 
important for research on mindfulness due to the recognised need for using valid measures in 
the assessment of interventions. In a recent study, the Five Facets of Mindfulness Inventory 
was validated in a sample of patients diagnosed with fibromyalgia. The results from this 
study showed that the data taken from the patient sample had a similar factorial structure to 
data taken from a healthy sample [28]. The purpose of the present study is to examine the 
psychometric properties of the Spanish version of the MAAS in a sample of patients 
diagnosed with fibromyalgia. 
Method 
Sample and procedure 
Sample size was calculated according to the recommended 10:1 ratio of the number of 
subjects to the number of test items [29]. Participants were recruited from the Pain Clinic 
(Santander, Spain) and the Fibromyalgia Unit of the Miguel Servet Hospital, Zaragoza 
(Spain). Recruitment took place during the year 2010. To be included in the study, patients 
had to be diagnosed with fibromyalgia by a rheumatologist according to American College of 
Rheumatology (ACR) criteria [30]. Patients were excluded if they had a medical or 
psychiatric disorder that impeded their ability to correctly answer the questionnaire. The 
sample consisted of 251 participants (10 men and 241 women), with a mean age of 52.4 years 
(SD = 8.4; Range = 31–70). One patient was excluded as a result of being diagnosed with 
schizophrenia, which, in the clinician’s point of view, limited the reliability of the 
questionnaire. On average, participants had suffered from FM for 7.9 years (SD = 2.3; range 
= 1–20), and 122 participants (48.8%) had been granted an invalidity pension. The majority 
of patients (N = 231; 92.4%) were taking one or more prescription drug. More than half of 
the patients (N = 131; 52.4%) suffered from some form of psychiatric morbidity, as assessed 
by the MINI Psychiatric Interview [31] (mainly depression and anxiety). A group of 21 
patients (8.4%) were also diagnosed with Posttraumatic Stress Disorder. The study 
questionnaires and protocol were approved by the Ethical Committee of the regional health 
authority, and patients signed a consent form attesting to their willingness to participate in the 
study. 
Instruments 
Mindful attention awareness scale (MAAS) 
The MAAS is a 15-item instrument measuring the general tendency to be attentive to and 
aware of one’s experiences in daily life [17]. Using a 6-point Likert-type scale (ranging from 
almost always to almost never), respondents rated how often they experienced acting as if 
they were on automatic pilot, being preoccupied, and not paying attention to the present 
moment (e.g.: “I could be experiencing some emotion and not be conscious of it until some 
time later”)..The scale showed an internal consistency of 0.82 and exhibited significant 
convergent and discriminant validity. Scores on the MAAS were significantly higher in 
mindfulness practitioners than in matched community controls. The Spanish version of the 
MAAS was used, and it has recently been shown to have good test-retest reliability and 
internal consistency in a sample of healthy Spanish subjects [22]. 
Chronic pain acceptance questionnaire (CPAQ) 
The CPAQ is a 20-item questionnaire designed to measure pain acceptance (e.g.: “It’s OK to 
experience pain”) [32]. All items are rated on a Likert-type scale, ranging from 0 (never true) 
to 6 (always true). The Spanish version of the scale has been validated [33], showing 
sufficient test-retest reliability and internal consistency. 
Pain catastrophizing scale (PCS) 
The PCS is a 13-item scale designed to assess individuals’ catastrophising cognitions by 
asking them to reflect on thoughts or feelings associated with present painful experiences 
(e.g.: “When I’m in pain I feel I can’t go on”) [34]. Each item is scored on a Likert-type 
scale, which ranges from 0 (not at all) to 4 (always). The Spanish version of this scale has 
been validated, [35] showing sufficient test-retest reliability and internal consistency. 
Injustice experience questionnaire (IEQ) 
The IEQ is a 12-item questionnaire that measures the frequency with which patients have 
thoughts concerning the unfairness of their illness (e.g.: “My life will never be the same”) 
[36]. Each question is answered using a 5-point scale, which ranges from 0 (never) to 4 (all 
the time). The Spanish version of this scale has been validated, [37] showing sufficient test-
retest reliability and internal consistency. 
The psychological inflexibility in pain scale (PIPS) [14] 
The PIPS is a 12-item scale developed to assess target variables in exposure and acceptance-
oriented treatments of chronic pain (e.g.: “I postpone things because of my pain”). We used 
the total scores resulting from this instrument in the final analyses of this study. The Spanish 
version of PIPS has been validated by our group” (personal communication)”. 
EuroQol (EQ-5D) 
The EQ-5D is a questionnaire composed of 7 items developed to measure a unique health 
status score [38]. The EQ-5D covers 5 dimensions of health: mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression. Each dimension is evaluated in 3 
categories (no problem, moderate problems, or extreme problems). In the present study, we 
used a validated Spanish version of EQ-5D [39]. 
Fibromyalgia impact questionnaire (FIQ) 
The Fibromyalgia Impact Questionnaire (FIQ) is a 10-item self-report questionnaire 
developed to measure the functional impairment of fibromyalgia patients [40]. The first item 
of the scale focuses on the patient's ability to carry out muscular activities. The next two 
items of the scale ask patients to indicate the number of days in the past week that they felt 
good and the number of instances that they missed work. Finally, the last seven items (i.e., 
ability to work, pain, fatigue, morning tiredness, stiffness, anxiety and depression) are 
measured with visual analogue scales. The Spanish version of this scale has been validated 
[41]. 
Statistical analyses 
Demographic data were analysed using the descriptive statistics of mean, standard deviation 
(SD) and range. Prior to conducting the statistical analyses, we examined data for univariate 
and multivariate outliers. In order to detect the presence of univariate outliers, the frequency 
distributions of each item was examined (values ≥ 3 standard deviations from the mean 
indicate univariate outliers). Screening for multivariate outliers was by carried out by means 
of the Mahalanobis distance scores for all cases (D2); A D2 probability ≤ 0.01 indicates the 
existence of multivariate outliers [42]. We did not detect any outliers, therefore all cases were 
retained for the statistical analyses. 
We used Confirmatory Factor Analysis (CFA) to analyse the dimensionality of the MAAS. 
We propose a one-factor model (with all items loading on one latent factor) and a two-factor 
model (Factor 1: items 1, 2, 4, 5, 7, 8, 9, 10, 11, 14, and 15; Factor 2: items 3, 6, 12, and 13) 
previously found with a principal component analysis. EQS software for Windows version 
6.1 [43] was used to conduct the CFA. The maximum likelihood with robust correction 
method was used to adjust for distributional problems in the data set. Although a model with 
a non-significant chi-square estimate is generally considered a model with good fit, Hu and 
Bentler [44] recommended combinational rules to evaluate model fit. Therefore, we analysed 
the following indices (values in parentheses denote goodness of fit standards): Comparative 
Fit Index and Goodness of Fit Index (CFI and GFI > 0.90) and Root Mean Square Error of 
Approximation and Standardized Root Mean-Square Residual (RMSEA and SRMR < 0.08). 
The Satorra–Bentler chi-square is a chi square fit index that corrects the statistic under 
distributional violations. To reduce the sensitivity of chi-square to sample size, the index is 
divided by the degrees of freedom. Ratios of 3 or smaller are indicative of an acceptable fit of 
the model [45]. We selected these statistics to measure fit because previous research 
corroborated their performance and stability [46]. 
We examined the internal consistency, test-retest, and construct validity of the MAAS. 
Cronbach's α coefficient [47] was used to analyse the internal consistency of the scale. 
Corrected item-total correlations, in which an item is correlated with the total scale score 
excluding itself, were tested for each item. Consistency of the MAAS total score over time 
(test-retest reliability) was assessed using the Intraclass Correlation Coefficient (ICC). 
Construct validity was examined by correlating the MAAS with theoretically related and 
unrelated constructs. Pearson’s correlations were performed to evaluate univariate 
relationships between the MAAS and the following criterion variables: chronic pain 
acceptance, pain catastrophising, perceived injustice, pain inflexibility, global function and 
quality of life. We used effect size criteria outlined by Cohen [48] to evaluate the substantive 
significance of correlations (i.e., large correlations are those >0.50, medium correlations 
range from 0.30 to 0.49, and small correlations range from 0.10 to 0.29). 
Results 
All items were examined in terms of mean, standard deviation, skewness and kurtosis. 
Univariate values approaching at least 2.0 for skewness and 7.0 for kurtosis indicate marked 
non-normality [42]. On the basis of the values displayed in Table 1, the data appear to show 
normality. 
Table 1 Means (M), standard deviation (SD), 95% Confidence Intervals (95% CIs), standardised factor loadings (λ one-factor solution), 
corrected item-total correlations (rtot), skewness and kurtosis for all MAAS items 
MAAS items (Spanish translation between parentheses) M (SD) 95% CIs λ rtot Skewness Kurtosis 
1. I could be experiencing some emotion and not be conscious of it until some time later (Puedo estar experimentando 
alguna emoción y no ser consciente hasta algún tiempo después) 
4.39 (1.6) 4.1-4.6 0.53 0.53 -.44 −1.22 
2. I break or spill things because of carelessness, not paying attention, or thinking of something else (Rompo o derramo 
cosas por descuido, por no prestar atención o por pensar en otra cosa). 
4.15 (1.7) 3.9-4.3 0.60 0.59 -.30 −1.38 
3. I find it difficult to stay focused on what’s happening in the present (Encuentro difícil permanecer focalizado en lo 
que está ocurriendo en el presente). 
3.34 (1.7) 3.1-3.5 0.60 0.59 .32 −1.13 
4. I tend to walk quickly to get where I’m going without paying attention to what I experience along the way (Tiendo a 
andar rápidamente para llegar a donde quiero ir sin prestar atención a lo que experimento a lo largo del camino). 
3.82 (1.8) 3.5-4 0.59 0.62 -.08 −1.50 
5. I tend not to notice feelings of physical tension or discomfort until they really grab my attention (Tiendo a no notar 
la tensión física o el malestar hasta que realmente despierta mi atención). 
4.61 (1.7) 4.4-4.8 0.44 0.42 -.83 -.82 
6. I forget a person’s name almost as soon as I’ve been told it for the first time (Olvido el nombre de una persona casi 
tan pronto como me lo dicen por primera vez). 
2.14 (1.6) 1.9-2.3 0.34 0.32 1.32 .37 
7. It seems that I am “running on automatic pilot,” without much awareness of what I’m doing (Parece que lleve puesto 
el “piloto automático” sin ser consciente de lo que estoy haciendo). 
3.31 (1.8) 3-3.5 0.81 0.76 .32 −1.29 
8. I rush through activities without being really attentive to them. (Hago las actividades diarias corriendo sin estar 
realmente atento a ellas). 
4.01 (1.7) 3.7-4.2 0.80 0.72 -.18 −1.46 
9. I get so focused on the goal I want to achieve that I lose touch with what I’m doing right now to get there (Estoy tan 
centrado en la meta que quiero alcanzar que pierdo la noción de lo que estoy haciendo). 
4.37 (1.8) 4.1-4.6 0.81 0.76 -.55 −1.28 
10. I do jobs or tasks automatically, without being aware of what I'm doing (Hago tareas o trabajos automáticamente 
sin ser consciente de lo que estoy haciendo). 
4.08 (1.8) 3.8-4.3 0.82 0.75 -.28 −1.47 
11. I find myself listening to someone with one ear, doing something else at the same time. (Me encuentro a mí mismo 
escuchando a alguien mientras hago algo al mismo tiempo). 
3.81 (1.7) 3.6-4 0.47 0.45 .03 −1.52 
12. I drive places on “automatic pilot” and then wonder why I went there (Conduzco a sitios con el “piloto automático” 
y entonces me pregunto qué hago allí). 
3.47 (1.9) 3.2-3.7 0.66 0.65 .14 −1.52 
13. I find myself preoccupied with the future or the past (Me encuentro a mí mismo preocupado por el futuro o el 
pasado). 
3.04 (1.8) 2.8-3.2 0.42 0.42 .50 −1.14 
14. I find myself doing things without paying attention (Me encuentro a mí mismo haciendo cosas sin prestar 
atención). 
3.68 (1.7) 3.4-3.9 0.80 0.76 .10 −1.39 
15. I snack without being aware that I’m eating (Picoteo sin ser consciente de lo que estoy comiendo). 4.52 (1.9) 4.2-4.7 0.49 0.48 -.81 −1.01 
As shown in Table 1, descriptive statistics were computed for all MAAS items. The mean 
total score on the MAAS was 56.7 (SD = 17.5; range 18–90). The highest score was obtained 
for item 5, which asks about the subject’s tendency not to notice feelings of physical tension 
and discomfort until these symptoms grab his or her attention. The lowest score was obtained 
for item 6, which asks about the tendency to forget the name of a person immediately. 
Confirmatory factor analysis (CFA) 
The original one-factor model [16] showed good fit indices [sbX2 = 185.43 (p < 0.001); CFI = 
0.94; GFI = 0.89; SRMR = 0.05; RMSA = 0.07 (0.05-0.08)]. The two-factor model, based on 
a previous exploratory factor analysis, obtained slightly better fit indices [sbX2 = 172.34 (p < 
0.001), CFI = 0.95, GFI = 0.90, SRMR = 0.05, RMSEA = 0.06 [0.05-0.08]]. The factor 
loadings of all MAAS items are shown in Table 1. 
Reliability 
Cronbach’s α for the MAAS was 0.90, indicating a high degree of internal consistency. 
Corrected item-total r correlation coefficients ranged between 0.32 and 0.76. With regard to 
temporal stability, a subsample of 162 patients from the original sample was randomly 
selected and contacted by phone in order to arrange a new interview to complete the 
instruments again 1–2 weeks later. This subsample included 5 men and 156 women, with a 
mean age of 50.8 years (SD = 7.9; Range = 33–68). Data from this subsample showed a test-
retest coefficient of 0.90 (CI = 0.89–0.92). 
Construct validity 
The convergent and divergent validity of the MAAS was calculated using Pearson’s product–
moment correlations with other relevant measures of psychopathology and measures of level 
of acceptance related to pain (see Table 2). Overall, with the exception of the EQ-5D, the 
measures correlated moderately and significantly with total scores on the MAAS. 
Table 2 Means (M) and standard deviations (SD) of study measures and association 
with MAAS total score in fibromyalgia patients 
 M (SD) MAAS 
CPAQ 47.6 (23.3) 0.37** 
PCS 24.3 (13.6) −0.47** 
FIQ 58.0 (15.0) −0.46** 
EIQ 30.1 (12.1) −0.45** 
PIPS 57.1 (18.2) −0.47** 
EQ-5D 47.1 (19.8) 0.15* 
*p < 0.05; ** p < 0.001. 
MAAS = Mindful Attention Awareness Scale; CPAQ = Chronic Pain Acceptance 
Questionnaire; PCS = Pain Catastrophizing Scale; FIQ = Fibromyalgia Impact Questionnaire; 
IEQ = Injustice Experience Questionnaire; PIPS = The Psychological Inflexibility in Pain 
Scale; EQ-5D = Health-related quality of life. 
Discussion 
The main objective of this study was to examine the psychometric properties of the Spanish 
version of the MAAS in a sample of patients with fibromyalgia. The MAAS scoring in our 
sample of patient s with FM (N = 251; M = 3.78; SD = 1.68) compared with the community 
adults sample studied in the original validation study (17) (N = 436; M = 4.20, SD = .69) is 
significantly lower (t = −4.592; gl = 685; p <0.001). These data show a tendency of FM 
patients to be less aware of their experience in daily life, acting more on “autopilot” and 
paying less attention to the present moment than healthy population does.” A descriptive 
analysis of the items and the total score showed a tendency of FM patients to be less aware of 
their experience in daily life, acting more on “autopilot” and paying less attention to the 
present moment than healthy population does. 
The results found using CFA are largely consistent with those reported in previous studies 
[17,22-27,49]. In the current sample, the one- and two-factor models both show adequate fit; 
however, we decided to retain the one-factor model for the set of reasons outlined below. 
First, the one-factor model met all the pre-established fit criteria, except for the chi-squared 
goodness-of-fit statistic, which was statistically significant (an unsurprising result, given that 
this statistic is highly sensitive and even small differences in model fit are statistically 
significant). Second, with the exception of item 6, all items loaded strongly on the latent 
factor (all factor loadings exceeded 0.40). Third, the underlying construct of the second latent 
factor in the two-factor model is difficult to interpret, other than on the basis of the item 
difficulty of the 4 loaded items. For instance, forgetting another person’s name almost as 
soon as one has been introduced for the first time is quite common, even amongst healthy 
individuals; this item had the lowest mean score. The two-factor model was proposed on the 
basis of a previous exploratory factor analysis, and it is well known that “artifactual 
difficulty” factors may be generated in unidimensional instruments when using exploratory 
techniques [50]. Fourth, the one-factor structure of the MAAS gained further support from 
the internal consistency analysis, which yielded an excellent Cronbach's α. Fifth, all items 
showed a corrected item-total correlation that was higher than conventional minimum value 
of 0.20. 
The test-retest reliability analysis yielded good temporal stability in a 1–2 week period. 
Regarding the correlation analyses, almost all of the measures included in the study 
correlated in the expected way with the MAAS total scores. These results are consistent with 
those found in other studies that demonstrate the importance of acceptance capacity in the 
experience of pain [5,6]. The only exception to this pattern of findings was the correlations 
between the MAAS and EQ-5D. However, these data are not surprising, given the results 
found by Boomershine [51], who performed a comprehensive evaluation of standardised 
assessment tools in the diagnosis of the fibromyalgia syndrome and in the assessment of 
fibromyalgia severity. In this evaluation, the EQ-5D was not among the recommended 
instruments for assessing HRQL or global improvement in these patients with FM. 
The two-factor structure was best supported by the data found in this research study, but 
results are not strong enough to conclude that this factorial model is best for the reasons 
already described. In both cases (uni and bifactorial models), the factor structure exhibited an 
acceptable fits, although more research is needed to explore the stability of the factor 
structure in FM and other chronic pain patients. 
This study has several limitations. First, as in any study using self-report measures, the results 
may have been influenced by participants’ acquiescence and need for social desirability. 
Furthermore, the validity of self-report measures of mindfulness, and the MAAS in 
particular, have been criticised previously [52]. One such criticism is that respondents might 
not be fully aware of their ability to experience the present moment. Second, we did not 
assess the instrument in populations of patients with other types of chronic pain, thus we did 
not confirm whether the factor structure is or is not specific to fibromyalgia. Third, the 
overwhelming proportion of women limits the generalizability of the findings to men. And 
finally, the difficulty in interpreting the confirmatory factor analyses warrants more research 
studies. 
Conclusion 
In conclusion, the MAAS has been shown to be a reliable instrument for measuring 
mindfulness in fibromyalgia patients. The results found through the factor structure analyses 
in this study should be examined in future studies. Such studies may compare the current 
results with those taken from clinical samples suffering from other types of chronic pain. 
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